Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GALR1 | P47211 | 1/20 | 0.32 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5964549 | 0.86 | PDE7B (0.34) | LMNAGALR1PDE7A | |
| SCHEMBL5963697 | 0.84 | SLC6A3 (0.34) | LMNAALDH1A1GALR1 | |
| SCHEMBL5963556 | 0.83 | KMT2A (0.34) | LMNARAB9ASMN1; SMN2PDE7A | |
| SCHEMBL5963816 | 0.81 | OPRM1 (0.35) | LMNAALDH1A1 | |
| SCHEMBL5963456 | 0.81 | SLC6A2 (0.36) | RAB9ASMN1; SMN2PDE7A | |
| SCHEMBL5963362 | 0.80 | GALR1 (0.34) | ALDH1A1RAB9ASMN1; SMN2GALR1 | |
| SCHEMBL6823442 | 0.80 | ALDH1A1 (0.32) | LMNAALDH1A1RAB9ASMN1; SMN2GALR1 | |
| SCHEMBL5963604 | 0.79 | POLB (0.35) | ALDH1A1RAB9ASMN1; SMN2GALR1 | |
| SCHEMBL5963597 | 0.78 | GALR1 (0.38) | LMNAALDH1A1RAB9ASMN1; SMN2GALR1 | |
| SCHEMBL5963482 | 0.78 | SLC6A2 (0.34) | LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1326851-B1 | SUBSTITUTED DIPEPTIDES AS GROWTH HORMONE SECRETAGOGUES | LILLY CO ELI (US) | 2004-06-30 | — | — | EP | claimed |
| US-7125840-B2 | Substituted dipeptides as growth hormone secretagogues | ELI LILLY AND COMPANY (US) | 2006-10-24 | — | — | US | disclosed |
| EP-1326851-B1 | SUBSTITUTED DIPEPTIDES AS GROWTH HORMONE SECRETAGOGUES | LILLY CO ELI (US) | 2004-06-30 | — | — | EP | disclosed |
| US-20040058971-A1 | Substituted dipeptides as growth hormone secretagogues | ELI LILLY AND COMPANY | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058971-A1 | Substituted dipeptides as growth hormone secretagogues | GHSR, GHRHR, SSTR4 | LMNA 4666/4885ALDH1A1 4282/4885RAB9A 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.